Jcl. Erve et al., ALKYLATION OF OXYTOCIN BY S-(2-CHLOROETHYL)GLUTATHIONE AND CHARACTERIZATION OF ADDUCTS BY TANDEM MASS-SPECTROMETRY AND EDMAN DEGRADATION, Chemical research in toxicology, 8(3), 1995, pp. 414-421
S-(2-Chloroethyl)glutathione (CEG), an alkylating agent formed by glut
athione conjugation with 1,2-dichloroethane (DCE), is able to alkylate
DNA and proteins. As a prelude to identification of specific protein
alkylation sites, the peptide oxytocin was alkylated by CEG, and tande
m mass spectrometry was used to identify the alkylation sites. It was
found that mono-, bis-, and tris-adducts can result from alkylation of
reduced oxytocin and that tandem mass spectrometry differentiated (S-
[2-(Cys(1))ethyl]glutathione)oxytocin (mono-adduct Cys-1) from (S-[2-(
Cys(6))ethyl]glutathione)oxytocin (mono-adduct Cys-6). Manual Edman de
gradation was used to eliminate the possibility that alkylation has oc
curred at Tyr-2 rather than at Cys-1 in the case of (S-[2-(Cys(1,6))et
hyl]glutathione)oxytocin (bis-adduct) and mono-adduct Cys-1. A mono-ad
duct homodimer resulting from alkylation at Cys-6 and disulfide bridge
formation through Cys-1 was also identified. Oxidized oxytocin formed
two minor adducts, representing less than 5% of the oxytocin present-
in the reaction mixture. These findings demonstrate that alkylation of
oxytocin by the episulfonium ion of CEG did occur, as evidenced by ta
ndem mass spectrometry, and that characterization of these adducts wil
l aid in the identification of alkylated amino acids in proteins expos
ed to CEG.